Pheronym Receives Grant to Achieve Commercialization Milestones
UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, an ag-biotech pest control company, received a $25,000 grant from Agstart to help reach commercialization milestones which the COVID-19 health crisis had forced to postpone or cancel. Pheronym is a pioneer in the use of nematode pheromones to control both beneficial and plant-parasitic nematodes, or […]
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a COVID 19 Vaccine Candidate
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience, a leading contract research organization focused on accelerating pre-clinical biologics product […]
ImmuneFX Gene Therapy Could Be a Game-Changer for Cancer Treatment
UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., a clinical-stage company that develops novel cell and gene therapies based out of Tampa, recently got FDA approval to expand human clinical trials with an innovative cancer vaccine. Grit Daily interviewed Morphogenesis CEO Dr. Patricia Lawman to get more information about this technology that could […]
Otonomy and AGTC Present Preclinical Results for Gene Therapy Hearing Loss Program
Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, announced preclinical results from the company’s gene therapy collaboration with UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, […]
After Acquisition, Tampa Biotech Firm Looks Toward COVID-19 Vaccine
Serendipity is the word Alan Joslyn uses to describe the meeting and eventual acquisition of a Gainesville-based biotech firm. “It’s not every day all of a sudden a private company falls in your lap that’s working in COVID-19,” said Alan Joslyn, CEO of UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in […]
Oragenics Acquires Noachis Terra Inc., to Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced its acquisition of UF Innovate | The Hub resident client Noachis Terra Inc., following its entry into a stock purchase agreement, to develop and […]
Just – Evotec Biologics to Collaborate With Ology Bioservices on Antibodies Against Coronavirus
Evotec SE, a drug discovery alliance and development partnership company focused on innovative product approaches with leading pharmaceutical and biotechnology companies, announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and […]
Foundation Park Building Sells for $12M
Avison Young real estate services announced the sale of a $12 million, newly-constructed 43,180-square-foot biotech and life science research facility at Foundation Park in Alachua. The sale, the largest in Alachua County since 2015 and part of a 1031 exchange, is the first of four buildings that are scheduled to be developed for UF Innovate […]
A Blood Test to Detect Traumatic Brain Injury
Traumatic brain injury (TBI) is hard to detect, and is sometimes called the “invisible injury.” Ron Hayes and Nancy Denslow, both scientists at the McKnight Brain Institute and the founders of UF startup and UF Innovate | Sid Martin Biotech alum Banyan Biomarkers, have developed a blood-based test that will make TBI detection and treatment […]
Ology Bioservices to Adapt Veroplex Cell Platform for Rapid Response to Viral Threats for Department of Defense
The Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies has awarded a contract valued at $27.3 million to UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to establish their proprietary Veroplex cell platform for rapid response to […]